The popularity of Viagra initially drove a period of growth for pharma, however recent developments present a murky outlook for investors. Generic competitors are eroding revenue, and continued litigation add further https://haseebpxyh156388.blogmazing.com/40015160/the-blue-pill-and-the-pharmaceutical-industry-a-risky-bet